InvestorsHub Logo
Followers 17
Posts 10861
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Saturday, 12/03/2022 4:40:39 PM

Saturday, December 03, 2022 4:40:39 PM

Post# of 44784
Reported herein are the final encouraging safety and efficacy results from a phase 1 study (NCT03002519).


https://ash.confex.com/ash/2022/webprogram/Paper169266.html
Bullish
Bullish